Valvular Heart Disease: New Concepts in Pathophysiology and Therapeutic Approaches

Mackram F Eleid1, Vuyisile T Nkomo1, Sorin V Pislaru1

  • 1Department of Cardiovascular Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota, USA;

Annual Review of Medicine
|November 18, 2022
PubMed

Insights

This review covers key updates in valvular heart disease, including atrial fibrillation

Area of Science:

  • Cardiology
  • Cardiovascular Medicine

Background:

  • Valvular heart disease (VHD) encompasses a range of conditions affecting heart valves.
  • Recent advancements necessitate an updated understanding of VHD diagnosis and management.
  • The interplay between VHD and other cardiovascular conditions is increasingly recognized.

Purpose of the Study:

  • To review recent advancements in valvular heart disease.
  • To highlight key areas including atrial fibrillation, rheumatic heart disease, and bicuspid aortic valve disease.
  • To discuss emerging therapeutic strategies, particularly transcatheter interventions.

Main Methods:

  • Literature review of recent studies and clinical guidelines.
  • Synthesis of information on epidemiological trends, diagnostic criteria, and treatment outcomes.
  • Focus on novel insights and evolving clinical practices in VHD management.

Main Results:

  • Atrial fibrillation significantly impacts VHD development and assessment.
  • Global strategies for rheumatic heart disease prevention are crucial.
  • Secondary mitral regurgitation requires specific management approaches.
  • Updated classification for bicuspid aortic valve disease is presented.
  • Moderate aortic stenosis carries significant cardiovascular risk.
  • Transcatheter therapies offer a growing treatment option.

Conclusions:

  • The field of valvular heart disease is rapidly evolving with new diagnostic and therapeutic insights.
  • A comprehensive approach is needed, integrating understanding of comorbidities and novel treatments.
  • Continued research and clinical updates are essential for optimal patient care in VHD.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
30
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
26
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
25
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
23
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.7K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
27